FACILITATION OF WHOLE BLOOD ANTI-PLATELET THERAPY MONITORING OVER EXTENDED SPECIMEN STORAGE TIME

FACILITATION OF WHOLE BLOOD ANTI-PLATELET THERAPY MONITORING OVER EXTENDED SPECIMEN STORAGE TIME

Background Dual anti-platelet therapy consisting of aspirin (ASA) and a P2Y12 inhibitor is a standard treatment to prevent thrombotic events in patients with acute coronary syndrome or myocardial infarction.

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Journal of the American College of Cardiology 2012-03, Vol.59 (13), p.E487-E487
Hauptverfasser: Dudaronek, Justyna M, Gelfand, Craig A, Moskowitz, Keith A
Format: Artikel
Sprache:eng
Schlagworte:
Acute coronary syndromes
Blood platelets
Cardiology
Cardiovascular
Collagen
Drug therapy
Heart attacks
Internal Medicine
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:Background Dual anti-platelet therapy consisting of aspirin (ASA) and a P2Y12 inhibitor is a standard treatment to prevent thrombotic events in patients with acute coronary syndrome or myocardial infarction.
ISSN:0735-1097
1558-3597
DOI:10.1016/S0735-1097(12)60488-4